
Comparison of Associations Between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis
Author(s) -
Jianbo Li,
Xuelian Liao,
Yue Zhou,
Luping Wang,
Hang Yang,
Wei Zhang,
Zhongwei Zhang,
Yan Kang
Publication year - 2021
Publication title -
shock
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.095
H-Index - 117
eISSN - 1540-0514
pISSN - 1073-2322
DOI - 10.1097/shk.0000000000001738
Subject(s) - medicine , methylprednisolone , ards , meta analysis , cochrane library , confidence interval , dexamethasone , prednisolone , randomized controlled trial , subgroup analysis , covid-19 , severity of illness , disease , lung , infectious disease (medical specialty)
The response to glucocorticoids treatment may be different between coronavirus disease 2019 (Covid-19) and severe acute respiratory syndrome (SARS).